Dr. HU has long been worked on the multidisciplinary comprehensive treatment of hematologic malignancies, specializing in early diagnosis of lymphoma, multiple myeloma, and leukemia. He focuses on comprehensive standardized treatment primarily using internal medicine chemotherapy, molecular targeted therapy, auto-HSCT/allo-HSCT and biologic therapy. He has conducted in-depth research on immunotherapy guided by biomarkers and is familiar with the latest international diagnostic and treatment standards for lymphoma. He has participated in over 20 international and domestic multi-center clinical studies, keeping abreast of the latest trends in the diagnosis and treatment of lymphoma and multiple myeloma internationally.